BioCentury
ARTICLE | Clinical News

GlycoMimetics Inc preclinical data

March 30, 2015 7:00 AM UTC

In a mouse model of pancreatic cancer, intraperitoneal GMI-1359 plus gemcitabine significantly reduced metastasis of the primary tumor to the liver and diaphragm vs. gemcitabine alone. In a mouse mode...